LexDanaLexDanabeta
Inventor

ERIKO NAKATA

Inventor
JP

Overview

3→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
Y02PClimate change mitigation technologies in the production or processing of goods10%
PatentTitleYear
12,109,209Use of morphinan derivatives for treatment of opioid delta receptor agonist-related disease202411,643,411Morphinan derivative202311,633,392Use of morphinan derivative for therapeutic treatment of opioid delta receptor agonist-related disease2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to NIPPON CHEMIPHAR CO (3)· patent assignee history
2023–2024Based in JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NIPPON CHEMIPHAR CO32023–2024
Locations
LocationPatentsSpan
JP32023–2024